Active Pharmaceutical Ingredients - API

  • We offer this product from a manufacturer in India specializing in Prescription drugs, Generic, OTC Products, Intravenous infusion, and Bulk Actives with 25years of experience. Both APIs and FDF?s are being manufactured at world-class manufacturing facilities.

  • We offer this product from a manufacturer in India with an ISO 9001 quality management system in a cGMP compliant facility and a strict HACCP program, KOSHER ? Star-K PAREVE status.

  • We offer this product from an Indian manufacturer having two-world class manufacturing sites, USFDA and COFEPRIS approved, WHO GMP certified, and have received AFM certificate from Japanese PMDA and recently concluded Korean FDA audit successfully. Further, the facility is also compliant with all other major regulatory bodies, including UKMHRA, EDQM, and TGA.

  • We offer this product from an Indian manufacturer having two-world class manufacturing sites, USFDA and COFEPRIS approved, WHO GMP certified, and have received AFM certificate from Japanese PMDA and recently concluded Korean FDA audit successfully. Further, the facility is also compliant with all other major regulatory bodies, including UKMHRA, EDQM, and TGA.

  • We offer this product from a manufacturer in India having a global manufacturing footprint that helps us deliver quality-assured products to our customers worldwide. In line with the growth strategy, we continue to ramp up capacities and automation to support the pipeline of complex generics and biotechnology products.

  • We offer this product from an Indian manufacturer having two-world class manufacturing sites, USFDA and COFEPRIS approved, WHO GMP certified, and have received AFM certificate from Japanese PMDA and recently concluded Korean FDA audit successfully. Further, the facility is also compliant with all other major regulatory bodies, including UKMHRA, EDQM, and TGA.

  • We offer this product from a manufacturer in India specializing in Prescription drugs, Generic, OTC Products, Intravenous infusion, and Bulk Actives with 25years of experience. Both APIs and FDF?s are being manufactured at world-class manufacturing facilities.

  • We are offering the product from our Indian manufacturer's USFDA, Japan PMDA, Korea FDA approved site. Their facility is COFEPRIS inspected for several products. Their R&D facility is recognized by the Department of Scientific and Industrial Research (DSIR, Ministry of Science and Technology, Government of India).
  • We offer this product from a manufacturer in India, a preferred vendor for many complex molecules requiring multistage synthesis.

  • We offer this product from the API manufacturing facility located in India consisting of different volumes of reactors suitable to carry the reactions like Catalytic hydrogenations, Chlorination?s, Nitration?s, Alkylation?s, Oxidations, Reductions, Resolutions(chemical), Couplings, etc. The manufacturing unit has a well-equipped ceanroom facility for finished product drying, milling, packing & storage.

    Quality Control is independent of production and is done in-house at the on-site QC laboratory, including GC & HPLC. Documentations are prepared and upgraded as per GMP guidelines like ICH Q7 and other international regulatory guidelines. Regular Internal Quality Audits and GMP Audits to ensure the continuous maintenance of Change control, Document control, Deviation Handling, Complaint handling, Validation Qualification of Equipment, and total Quality system. The unit has an excellent laboratory to conduct experiments on existing products and other new molecules development.

  • We are offering the product from our Indian manufacturer's USFDA, Japan PMDA, Korea FDA approved site. Their facility is COFEPRIS inspected for several products. Their R&D facility is recognized by the Department of Scientific and Industrial Research (DSIR, Ministry of Science and Technology, Government of India).
  • We offer this product from a manufacturer in India having a global manufacturing footprint that helps us deliver quality-assured products to our customers worldwide. In line with the growth strategy, we continue to ramp up capacities and automation to support the pipeline of complex generics and biotechnology products.

Go to Top